We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Acadia (ACHC) Starts Construction of Malden's JV Facility
Read MoreHide Full Article
Acadia Healthcare Company, Inc. (ACHC - Free Report) recently commenced the construction of a behavioral health hospital in Malden, MA. The facility, equipped with 144 beds, will be built as a result of the joint venture partnership between ACHC and the leading integrated health system of Massachusetts, Tufts Medicine.
The joint venture between the two healthcare providers was inked in June 2022 and the proposed hospital is expected to commence operations in fall 2025. It will provide an extensive suite of inpatient behavioral healthcare and intensive outpatient services, to extend high-quality care to patients residing in the greater Boston area, irrespective of age. The hospital will also work closely with local organizations and first responders of the Malden community to serve patients better.
Backed by specialized clinical teams, the new facility will enable Acadia Healthcare to boost access to behavioral health services across the targeted region. It will also act as a center for training psychiatry and other behavioral health professionals as well as students and residents from the Tufts University School of Medicine. With the sufficient availability of behavioral health expertise, the Malden hospital will serve the beneficial purpose of offering uninterrupted access to in-demand behavioral health services.
Partnering with Tufts Medicine will provide an in-depth understanding of the region’s diversified patient needs to Acadia Healthcare, backed by which it will be able to bring about improved patient outcomes. Tufts Medicine seems to have an extensive footprint of healthcare facilities, home care network and physician network across Massachusetts. With a care team comprising over 15,000 members, it caters to more than 1.5 million patients every year.
One of the components of the growth strategy of Acadia Healthcare is forming joint ventures with healthcare organizations situated in various U.S. communities. Bed additions resulting from such initiatives offer a means for ACHC to serve a greater number of patients and earn more revenues from rendering its credible behavioral healthcare services.
During 2023, 293 beds were added through the inauguration of one wholly-owned facility and two joint venture facilities. The company has 21 joint venture partnerships in place, with the latest one being with the Texas-based integrated healthcare system, Ascension Seton, in a bid to provide enhanced behavioral healthcare services across Austin and neighboring communities.
Management anticipates to add roughly 800 beds via the opening of wholly-owned and joint venture facilities in 2024. The continued incidence of mental health issues among Americans is also likely to sustain the solid demand for behavioral health care services in the days ahead. Apart from entering into joint ventures, other growth strategies of Acadia Healthcare include expansions of existing facilities, establishment of de novo facilities, pursuing acquisitions and enhancement of its care services suite.
Shares of Acadia Healthcare have risen 11.1% in the past year compared with the industry’s 28.3% growth.
Lantheus’ earnings surpassed the Zacks Consensus Estimate in each of the last four quarters, the average beat being 14.84%. The Zacks Consensus Estimate for LNTH’s 2024 earnings suggests an improvement of 5.6%, while the consensus mark for revenues indicates growth of 10.3% from the respective year-ago figures.
The consensus estimate for LNTH’s 2024 earnings has moved 5.1% north in the past 60 days. Shares of Lantheus have declined 22.2% in the past year.
Cigna’s earnings surpassed estimates in each of the last four quarters, the average surprise being 2.94%. The Zacks Consensus Estimate for CI’s 2024 earnings indicates a 13% rise, while the consensus mark for revenues suggests an improvement of 20.4% from the respective prior-year figures.
The consensus mark for CI’s 2024 earnings has moved 0.4% north in the past 60 days. Shares of Cigna have gained 43.8% in the past year.
ShockWave Medical’s earnings outpaced estimates in three of the trailing four quarters and missed the mark once, the average surprise being 13.55%. The Zacks Consensus Estimate for SWAV’s 2024 earnings indicates a 27% rise, while the consensus mark for revenues suggests an improvement of 26.1% from the respective prior-year figures.
The consensus mark for SWAV’s 2024 earnings has moved up 7.7% in the past 60 days. Shares of ShockWave Medical have gained 55.1% in the past year.
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Shutterstock
Acadia (ACHC) Starts Construction of Malden's JV Facility
Acadia Healthcare Company, Inc. (ACHC - Free Report) recently commenced the construction of a behavioral health hospital in Malden, MA. The facility, equipped with 144 beds, will be built as a result of the joint venture partnership between ACHC and the leading integrated health system of Massachusetts, Tufts Medicine.
The joint venture between the two healthcare providers was inked in June 2022 and the proposed hospital is expected to commence operations in fall 2025. It will provide an extensive suite of inpatient behavioral healthcare and intensive outpatient services, to extend high-quality care to patients residing in the greater Boston area, irrespective of age. The hospital will also work closely with local organizations and first responders of the Malden community to serve patients better.
Backed by specialized clinical teams, the new facility will enable Acadia Healthcare to boost access to behavioral health services across the targeted region. It will also act as a center for training psychiatry and other behavioral health professionals as well as students and residents from the Tufts University School of Medicine. With the sufficient availability of behavioral health expertise, the Malden hospital will serve the beneficial purpose of offering uninterrupted access to in-demand behavioral health services.
Partnering with Tufts Medicine will provide an in-depth understanding of the region’s diversified patient needs to Acadia Healthcare, backed by which it will be able to bring about improved patient outcomes. Tufts Medicine seems to have an extensive footprint of healthcare facilities, home care network and physician network across Massachusetts. With a care team comprising over 15,000 members, it caters to more than 1.5 million patients every year.
One of the components of the growth strategy of Acadia Healthcare is forming joint ventures with healthcare organizations situated in various U.S. communities. Bed additions resulting from such initiatives offer a means for ACHC to serve a greater number of patients and earn more revenues from rendering its credible behavioral healthcare services.
During 2023, 293 beds were added through the inauguration of one wholly-owned facility and two joint venture facilities. The company has 21 joint venture partnerships in place, with the latest one being with the Texas-based integrated healthcare system, Ascension Seton, in a bid to provide enhanced behavioral healthcare services across Austin and neighboring communities.
Management anticipates to add roughly 800 beds via the opening of wholly-owned and joint venture facilities in 2024. The continued incidence of mental health issues among Americans is also likely to sustain the solid demand for behavioral health care services in the days ahead. Apart from entering into joint ventures, other growth strategies of Acadia Healthcare include expansions of existing facilities, establishment of de novo facilities, pursuing acquisitions and enhancement of its care services suite.
Shares of Acadia Healthcare have risen 11.1% in the past year compared with the industry’s 28.3% growth.
Image Source: Zacks Investment Research
ACHC currently has a Zacks Rank #4 (Sell).
Stocks to Consider
Some better-ranked stocks in the Medical space are Lantheus Holdings, Inc. (LNTH - Free Report) , The Cigna Group (CI - Free Report) and Shockwave Medical, Inc. (SWAV - Free Report) . While Lantheus currently sports a Zacks Rank #1 (Strong Buy), Cigna and ShockWave Medical carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Lantheus’ earnings surpassed the Zacks Consensus Estimate in each of the last four quarters, the average beat being 14.84%. The Zacks Consensus Estimate for LNTH’s 2024 earnings suggests an improvement of 5.6%, while the consensus mark for revenues indicates growth of 10.3% from the respective year-ago figures.
The consensus estimate for LNTH’s 2024 earnings has moved 5.1% north in the past 60 days. Shares of Lantheus have declined 22.2% in the past year.
Cigna’s earnings surpassed estimates in each of the last four quarters, the average surprise being 2.94%. The Zacks Consensus Estimate for CI’s 2024 earnings indicates a 13% rise, while the consensus mark for revenues suggests an improvement of 20.4% from the respective prior-year figures.
The consensus mark for CI’s 2024 earnings has moved 0.4% north in the past 60 days. Shares of Cigna have gained 43.8% in the past year.
ShockWave Medical’s earnings outpaced estimates in three of the trailing four quarters and missed the mark once, the average surprise being 13.55%. The Zacks Consensus Estimate for SWAV’s 2024 earnings indicates a 27% rise, while the consensus mark for revenues suggests an improvement of 26.1% from the respective prior-year figures.
The consensus mark for SWAV’s 2024 earnings has moved up 7.7% in the past 60 days. Shares of ShockWave Medical have gained 55.1% in the past year.